Skip to main content

Femtrace FDA Approval History

FDA Approved: Yes (Discontinued) (First approved August 20, 2004)
Brand name: Femtrace
Generic name: estradiol acetate
Dosage form: Tablets
Company: Warner Chilcott
Treatment for: Postmenopausal Symptoms

Marketing Status: Discontinued

Femtrace (estradiol) is an oral estrogen indicated for the relief of postmenopausal vasomotor symptoms.

Development timeline for Femtrace

Aug 20, 2004Approval Femtrace Warner Chilcott - Treatment for Menopausal Vasomotor Symptoms

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.